Table 1.
Clinical and laboratory details of −ICH cases
No. | Mother | Newborn | anti-αvβ3 (OD) | ||||||
---|---|---|---|---|---|---|---|---|---|
gravida/para | antibody specificity | week of gestation | sex | platelet nadir (G/l) | ICH | other bleeding symptoms | bleeding excluded by | ||
1 | II/I | HPA-1a | 28+4 | M | 12 | no | H | ultrasound | 0.300 |
2 | II/II | HPA-1a | 38+4 | F | 22 | no | P, H | ultrasound | 0.033 |
3 | NR | HPA-1a | 36+5 | M | 29 | no | P | ultrasound | 0.048 |
4 | I/I | HPA-1a | 40+0 | M | 6 | no | P | ultrasound | 0.320 |
5 | NR | HPA-1a | 40+2 | F | 11 | no | P | ultrasound | 0.030 |
6 | NR | HPA-1a | 28+0 | F | 24 | no | P | ultrasound | 0.152 |
7 | III/III | HPA-1a | 36+5 | F | 13 | no | P | ultrasound | 0.324 |
8 | I/I | HPA-1a | 41+0 | F | 5 | no | P | ultrasound | 0.273 |
9 | I/I | HPA-1a | 38+0 | M | 15 | no | P | ultrasound | 0.238 |
10 | I/I | HPA-1a | 41+2 | M | 24 | no | P | ultrasound | 0.215 |
11 | I/I | HPA-1a | 38+2 | M | 15 | no | P, H | ultrasound | 0.089 |
12 | I/I | HPA-1a | 40+0 | F | 3 | no | P, H | ultrasound | 0.174 |
13 | III/II | HPA-1a | 37+5 | F | 13 | no | P, H | ultrasound | 0.084 |
14 | III/III | HPA-1a | 39+3 | F | 18 | no | H | ultrasound | 0.098 |
15 | I/I | HPA-1a | 38+4 | M | 13 | no | P, H | ultrasound | 0.167 |
16 | IV/II | HPA-1a | 34+5 | NR | 7 | no | P | ultrasound | 0.204 |
17 | IV/III | HPA-1a | 40+0 | M | 18 | no | P | ultrasound | 0.289 |
18 | II/II | HPA-1a | 40+0 | M | 9 | no | P, U | ultrasound | 0.245 |
NR = not reported; P = petechiae; H = hematoma; U = hematuria